Incyte, a Delaware-founded global biopharmaceutical company with a portfolio of treatments across oncology, inflammation and autoimmunity, has chosen downtown Wilmington, Delaware, for its new headquarters.   It will renovate two buildings in downtown Wilmington, whose 517,307 square feet will almost double the company’s Delaware footprint. The new space will allow Incyte to continue building its Delaware employee base by bringing in more than 300 employees currently working in Chadds Ford, Pe...